Cargando…

Enhanced cytotoxicity of PARP inhibition in mantle cell lymphoma harbouring mutations in both ATM and p53

Poly-ADP ribose polymerase (PARP) inhibitors have shown promise in the treatment of human malignancies characterized by deficiencies in the DNA damage repair proteins BRCA1 and BRCA2 and preclinical studies have demonstrated the potential effectiveness of PARP inhibitors in targeting ataxia-telangie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Williamson, Chris T, Kubota, Eiji, Hamill, Jeffrey D, Klimowicz, Alexander, Ye, Ruiqiong, Muzik, Huong, Dean, Michelle, Tu, LiRen, Gilley, David, Magliocco, Anthony M, McKay, Bruce C, Bebb, D Gwyn, Lees-Miller, Susan P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	WILEY-VCH Verlag 2012
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3443945/ https://www.ncbi.nlm.nih.gov/pubmed/22416035 http://dx.doi.org/10.1002/emmm.201200229

Ejemplares similares

ATM-Deficient Colorectal Cancer Cells Are Sensitive to the PARP Inhibitor Olaparib()
por: Wang, Chen, et al.
Publicado: (2017)

Loss of tumour-specific ATM protein expression is an independent prognostic factor in early resected NSCLC
por: Petersen, Lars F., et al.
Publicado: (2017)

Predicting PARP inhibitor sensitivity and resistance
por: Bebb, D. Gwyn, et al.
Publicado: (2012)

Low ATM protein expression in malignant tumor as well as cancer-associated stroma are independent prognostic factors in a retrospective study of early-stage hormone-negative breast cancer
por: Feng, Xiaolan, et al.
Publicado: (2015)

Low Ki67/high ATM protein expression in malignant tumors predicts favorable prognosis in a retrospective study of early stage hormone receptor positive breast cancer
por: Feng, Xiaolan, et al.
Publicado: (2016)

Interaction between ATM and PARP-1 in response to DNA damage and sensitization of ATM deficient cells through PARP inhibition
por: Aguilar-Quesada, Rocío, et al.
Publicado: (2007)

Correction: Combined poly-ADP ribose polymerase and ataxia-telangiectasia mutated/Rad3-related inhibition targets ataxia-telangiectasia mutated-deficient lung cancer cells
por: Jette, Nicholas R., et al.
Publicado: (2020)

Combined poly-ADP ribose polymerase and ataxia-telangiectasia mutated/Rad3-related inhibition targets ataxia-telangiectasia mutated-deficient lung cancer cells
por: Jette, Nicholas R., et al.
Publicado: (2019)

Cancer Cells Haploinsufficient for ATM Are Sensitized to PARP Inhibitors by MET Inhibition
por: D’Ambrosio, Concetta, et al.
Publicado: (2022)

ATM-depletion in breast cancer cells confers sensitivity to PARP inhibition
por: Gilardini Montani, Maria Saveria, et al.
Publicado: (2013)

RYBP Sensitizes Cancer Cells to PARP Inhibitors by Regulating ATM Activity
por: Maybee, Deanna V., et al.
Publicado: (2022)

CXCR4 expression in lung carcinogenesis: Evaluating gender-specific differences in survival outcomes based on CXCR4 expression in early stage non-small cell lung cancer patients
por: Fung, Andrea S., et al.
Publicado: (2021)

A Case of Bowen’s Disease and Small-Cell Lung Carcinoma: Long-Term Consequences of Chronic Arsenic Exposure in Chinese Traditional Medicine
por: Lee, Linda, et al.
Publicado: (2005)

The emerging role of nimotuzumab in the treatment of non-small cell lung cancer
por: Boland, William, et al.
Publicado: (2010)

Absence of mutations in the ATM gene in forty-seven cases of sporadic breast cancer
por: Bebb, D G, et al.
Publicado: (1999)

Combined PARP and ATR inhibition potentiates genome instability and cell death in ATM-deficient cancer cells
por: Lloyd, Rebecca L., et al.
Publicado: (2020)

Differential responses to taxanes and PARP inhibitors in ATM‐ versus BRCA2‐mutated metastatic castrate‐resistant prostate cancer
por: Su, Christopher T., et al.
Publicado: (2022)

The PARP3- and ATM-dependent phosphorylation of APLF facilitates DNA double-strand break repair
por: Fenton, Amanda L., et al.
Publicado: (2013)

ATM depletion induces proteasomal degradation of FANCD2 and sensitizes neuroblastoma cells to PARP inhibitors
por: Parvin, Sultana, et al.
Publicado: (2023)

The role of water in Earth's mantle
por: Ohtani, Eiji
Publicado: (2020)

Symptoms and Experiences with Small Cell Lung Cancer: A Mixed Methods Study of Patients and Caregivers
por: Bebb, D. Gwyn, et al.
Publicado: (2023)

53BP1 depletion causes PARP inhibitor resistance in ATM-deficient breast cancer cells
por: Hong, Ruoxi, et al.
Publicado: (2016)

Inhibition of DNA Repair by Inappropriate Activation of ATM, PARP, and DNA-PK with the Drug Agonist AsiDNA
por: Berthault, Nathalie, et al.
Publicado: (2022)

Cold harbour /
por: Higgins, Jack, 1929-2022
Publicado: (1990)

Erratum to: 53BP1 depletion causes PARP inhibitor resistance in ATM-deficient breast cancer cells
por: Hong, Ruoxi, et al.
Publicado: (2016)

Bi-allelic amplification of ATM gene in blastoid variant of mantle cell lymphoma: a novel mechanism of inactivation due to chromoanagenesis?
por: Ortega, Veronica, et al.
Publicado: (2021)

Exploiting PRMT5 as a target for combination therapy in mantle cell lymphoma characterized by frequent ATM and TP53 mutations
por: Che, Yuxuan, et al.
Publicado: (2023)

A dual-targeting ruthenium nanodrug that inhibits primary tumor growth and lung metastasis via the PARP/ATM pathway
por: Lu, Yu, et al.
Publicado: (2021)

Physical activity and diet behaviour in colorectal cancer patients receiving chemotherapy: associations with quality of life
por: Stephenson, Lynette E, et al.
Publicado: (2009)

Characterization of a murine model of metastatic human non-small cell lung cancer and effect of CXCR4 inhibition on the growth of metastases
por: Singla, Arvind K., et al.
Publicado: (2015)

Transient HSP90 inhibition enhances the sensitivity of mantle cell lymphoma to poly (ADP-ribose) polymerase (PARP) inhibitors
por: Shi, Chaowen, et al.
Publicado: (2023)

Peripheral blood complete remission after splenic irradiation in Mantle-Cell Lymphoma with 11q22-23 deletion and ATM inactivation
por: Filippi, Andrea Riccardo, et al.
Publicado: (2006)

The prevalence and prognostic significance of estrogen receptor beta expression in non-small cell lung cancer
por: Enwere, Emeka K., et al.
Publicado: (2020)

DIPG-19. TARGETING ATM MUTATION IN METASTATIC DIFFUSE MIDLINE GLIOMA – A CASE OF SUSTAINED RESPONSE USING PARP INHIBITOR
por: Tsui, Karen, et al.
Publicado: (2020)

PARP14 is a PARP with both ADP-ribosyl transferase and hydrolase activities
por: Đukić, Nina, et al.
Publicado: (2023)

On an Outbreak of Cholera in Bombay Harbour
por: Arnott, James
Publicado: (1878)

Circumscribed Congenital Alopecias Harbouring Dual Lesions
por: Rao, Shalinee, et al.
Publicado: (2010)

Lithospheric mantle buoyancy: the role of tectonic convergence and mantle composition
por: Boonma, K., et al.
Publicado: (2019)

A Comparison of Patients’ and Physicians’ Knowledge and Expectations Regarding Precision Oncology Tests
por: Dehar, Navdeep, et al.
Publicado: (2022)

The Combination of ATM and Chk1 Inhibitors Induces Synthetic Lethality in Colorectal Cancer Cells
por: Tozaki, Yuri, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9pbgf1bnhuqai4lsgo0g3qsbbn